Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Florence

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
AIDS (London, England)|June 16, 2001
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatmentW Schrooten, R Colebunders, M Youle, et al.
International Journal of STD & AIDS|August 17, 2004
Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centreW Schrooten, E Florence, C Dreezen, et al.
AIDS Care|February 15, 2001
Antiretroviral treatments used among adults with HIV infection in EuropeR Colebunders, W Schrooten, C Dreezen, et al.
BMC Infectious Diseases|November 5, 2015
Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrantsD Van Beckhoven, E Florence, J Ruelle, et al.
HIV Medicine|February 26, 2015
Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialE Denning, S Sharma, M Smolskis, et al.
HIV Medicine|July 30, 2015
Late presentation to HIV testing is overestimated when based on the consensus definitionA Sasse, E Florence, A Pharris, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
AIDS (London, England)|June 16, 2001
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatmentW Schrooten, R Colebunders, M Youle, et al.
International Journal of STD & AIDS|August 17, 2004
Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centreW Schrooten, E Florence, C Dreezen, et al.
AIDS Care|February 15, 2001
Antiretroviral treatments used among adults with HIV infection in EuropeR Colebunders, W Schrooten, C Dreezen, et al.
BMC Infectious Diseases|November 5, 2015
Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrantsD Van Beckhoven, E Florence, J Ruelle, et al.
HIV Medicine|February 26, 2015
Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialE Denning, S Sharma, M Smolskis, et al.
HIV Medicine|July 30, 2015
Late presentation to HIV testing is overestimated when based on the consensus definitionA Sasse, E Florence, A Pharris, et al.
Pageof 6